IVD Reagent develop for SARS-CoV-2 {{ currentPage ? currentPage.title : "" }}

Coronaviruses (CoVs) are enveloped positive-sense RNA viruses, which are characterized by club-like spikes projecting from its surface. They are important pathogens capable of infecting respiratory, gastrointestinal, hepatic, and central nervous system of human, livestock, avian, and many wild animals. The possibility of CoVs transmission from animals to human has been proved since the outbreaks of the severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012, and more recently in December 2019–January 2020 of a novel Coronavirus (SARS-CoV-2).

SARS-CoV-2 is a new member of the genus Betacoronavirus. Its origins have traced back to the seafood wholesale market in Wuhan, China. Resulting from the human-to-human transmission, the number of cases of SARS-CoV-2 infections in China is rising dramatically and also worldwide. At present, SARS-CoV-2-specific therapies and vaccines are under development and the main treatments are supportive.

Learn more: IVD Reagent develop for SARS-CoV-2

{{{ content }}}